Zobrazeno 1 - 10
of 360
pro vyhledávání: '"Daobin Zhou"'
Autor:
Xialu Lan, Fujing Zhang, Chen Yang, Wei Su, Jianhua Du, Shuangjiao Liu, Miao Chen, Bing Han, Daobin Zhou, Junling Zhuang
Publikováno v:
Chronic Diseases and Translational Medicine, Vol 10, Iss 1, Pp 62-68 (2024)
Abstract Background This study assessed the effect of standardized efficacy markers on prognosis in patients with newly diagnosed multiple myeloma (MM) during the induction phase of treatment with bortezomib, cyclophosphamide, and dexamethasone (BCD)
Externí odkaz:
https://doaj.org/article/2182837c9d5d453cb7c981b198982ff2
Autor:
Hongyun Chen, Congwei Jia, Daobin Zhou, Danqing Zhao, Yan Zhang, Hao Cai, Qiang Wang, Yueyi Zhang, Wei Zhang
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 57, Iss , Pp 101048- (2024)
Indolent natural killer cell lymphoproliferative disorder of the gastrointestinal tract (iNKLPD-GI) is an uncommon, recently recognized lymphoid proliferation of mature NK cells primarily manifesting in the GI tract. Unlike NK/T lymphoma, iNKLPD-GI e
Externí odkaz:
https://doaj.org/article/aba78a70d85f42338bae4e010c945b61
Publikováno v:
Cancer Medicine, Vol 13, Iss 9, Pp n/a-n/a (2024)
Abstract Background Consolidation therapy improves the duration of response among patients with primary central nervous system lymphoma (PCNSL). Lenalidomide maintenance has shown encouraging results in older patients with PCNSL. Herein, we performed
Externí odkaz:
https://doaj.org/article/56acd254185440ec80880ef8386406d8
Autor:
Zhuo-Fan Xu, Li Yuan, Yan Zhang, Wei Zhang, Chong Wei, Wei Wang, Danqing Zhao, Daobin Zhou, Jingnan Li
Publikováno v:
Hematology Reports, Vol 16, Iss 1, Pp 63-75 (2024)
The gut microbiome (GMB) has been extensively reported to be associated with the development and prognosis of human diseases. This study aims to investigate the relationship between GMB composition and chemotherapy efficacy in diffuse large B-cell ly
Externí odkaz:
https://doaj.org/article/da4c1a67183747178c986ae49b00de0a
Autor:
Jinrong Zhao, Chong Wei, Shuqing Wang, Yan Zhang, Wei Wang, Danqing Zhao, Zi Wang, Zhipeng Zhou, Jing Bai, Wei Zhang, Daobin Zhou
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-11 (2023)
Abstract CAR-T cell therapy did not achieve the desired efficacy in some patients with diffuse large B-cell lymphoma (DLBCL). We conducted single-cell RNA and TCR sequencing as well as methylation chip profiling of peripheral blood samples in DLBCL p
Externí odkaz:
https://doaj.org/article/a41e8a769c7745958284f697443dded7
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Germline mutations in genes involved in perforin-granzyme-mediated cytotoxicity such as PRF1, UNC13D, STX11, and STXBP2 were known to cause familial hemophagocytic lymphohistiocytosis (FHL). In this study, we reported a unique group of 3 patients wit
Externí odkaz:
https://doaj.org/article/6da106d1148e4fcf8883f1b176a88a25
Autor:
Yuqin Song, Keshu Zhou, Dehui Zou, Dengju Li, Jianda Hu, Haiyan Yang, Huilai Zhang, Jie Ji, Wei Xu, Jie Jin, Fangfang Lv, Ru Feng, Sujun Gao, Daobin Zhou, Constantine S. Tam, David Simpson, Michael Wang, Tycel J. Phillips, Stephen Opat, Cheng Fang, Shaohui Sun, Jun Zhu
Publikováno v:
Cancer Medicine, Vol 12, Iss 18, Pp 18643-18653 (2023)
Abstract Background We previously reported results of a pooled analysis of two zanubrutinib studies in relapsed or refractory (R/R) MCL showing better survival outcomes when zanubrutinib is used in second‐line versus later‐line. Here, we present
Externí odkaz:
https://doaj.org/article/1bc9e62404054e8489c6afc31806b1b4
Publikováno v:
Clinical and Translational Medicine, Vol 14, Iss 1, Pp n/a-n/a (2024)
Externí odkaz:
https://doaj.org/article/bda279636344424b9dc88d568cdab481
Publikováno v:
Cancers, Vol 16, Iss 5, p 860 (2024)
Background: This systematic review and meta-analysis aimed to evaluate the efficacy and safety of Bruton tyrosine kinase inhibitors (BTKis) for central nervous system lymphoma (CNSL). Methods: A systematic review was carried out to identify relevant
Externí odkaz:
https://doaj.org/article/e838ab958bcd4fca92380f6bbb653107
Publikováno v:
Hematology, Vol 27, Iss 1, Pp 757-764 (2022)
Objectives To analyse the clinical characteristics and therapeutic response of Chinese patients with primary extranodal diffuse large B-cell lymphoma DLBCL (PE-DLBCL).Methods We analysed the clinical features and outcomes of 197 patients who were new
Externí odkaz:
https://doaj.org/article/3616547545f7423da7b0221de74d07c8